Elisabeth Buur Stougaard

9PUBLICATIONS
26CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsPoverty, inclusivity and wellbeingMajor global burdens of diseaseAboriginal and Torres Strait Islander theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 29, 2025
The Steno 1 study: Multifactorial intervention to reduce cardiovascular disease in type 1 diabetes-rationale and protocol of the prospective, randomized, open-labelled multicentre study.

Elisabeth B Stougaard, Mads R Andersen, Jonatan I Bagger

|Mar 15, 2025
Combining SGLT2is, GLP1-RAs and nsMRAs in Diabetes: A Scoping Review of Current and Future Perspectives.

Elisabeth Buur Stougaard, Viktor Rotbain Curovic, Tine Willum Hansen

|Oct 16, 2024
Slowing the progression of diabetic and non-diabetic kidney disease: A summary of the current evidence base for sodium-glucose co-transporter-2 inhibitors.

Viktor Rotbain Curovic, Elisabeth Buur Stougaard, Tine Willum Hansen

|Jul 11, 2023
Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study.

Elisabeth B Stougaard, Hanan Amadid, Esben Søndergaard

|Mar 05, 2023
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes.

Elisabeth B Stougaard, Peter Rossing, Dorte Vistisen

|Oct 20, 2022
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.

Elisabeth B Stougaard, Peter L Kristensen, Urd Kielgast

Pageof 2

Frequent Collaborators

3 joint publications

Peter Rossing

3 joint publications

Viktor Rotbain Curovic

2 joint publications

Remi Rabasa-Lhoret

2 joint publications

Tine Willum Hansen